CARDIUM THRPTCS

Inactive Instrument

Insiders CARDIUM THRPTCS Nyse

Equities

End-of-day quote Nyse Other stock markets
- ^USD	-

2022	Gene Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt	CI
2021	Gene Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Gene Biotherapeutics, Inc. Announces Resignation of Murray H. Hutchison from the Board	28/07/21	CI
Gene Biotherapeutics, Inc. Announces Management Changes	28/05/20	CI
Gene Biotherapeutics, Inc. Appoints James L. Grainer as Chief Financial Officer	28/05/20	CI
Gene Biotherapeutics Inc. Announces Retirement of Gerald J. Lewis from its Board of Directors	20/03/19	CI
Taxus Cardium Pharmaceuticals Group, Inc. Announces Board Retirements	14/12/16	CI
Dennis Mulroy Resigns as Chief Financial Officer of Taxus Cardium Pharmaceuticals Group Inc on April 3, 2015	03/04/15	CI
TaxuCardium Pharmaceuticals Group Inc. Announces Election of New Directors	15/01/15	CI
Cardium Therapeutics, Inc. has Changed its Name to Taxus Cardium Pharmaceuticals Group Inc	17/03/14	CI
Cardium Therapeutics Inc. Announces Medical Advisory Board to Support Excellagen Advanced Wound Care Product	20/09/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer